Bnp Paribas Asset Management Holding S.A. Clovis Oncology, Inc. Transaction History

Bnp Paribas Asset Management Holding S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$29.37 - $49.48 $4.16 Million - $7.01 Million	-141,766 Closed	0 $0
Q2 2018 Aug 01, 2018	BUY	$42.06 - $62.4 $1.85 Million - $2.74 Million	43,891 Added 44.84%	141,766 $6.45 Million
Q1 2018 May 07, 2018	SELL	$50.12 - $67.72 $391,387 - $528,825	-7,809 Reduced 7.39%	97,875 $5.17 Million
Q4 2017 Feb 01, 2018	BUY	$57.69 - $84.58 $117,053 - $171,612	2,029 Added 1.96%	105,684 $7.19 Million
Q3 2017 Nov 02, 2017	BUY	$67.17 - $84.81 $6.96 Million - $8.79 Million	103,655	103,655 $8.54 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.